Skip to main content

Closed

CRIS: Curis, Inc. Stock Analysis | finqOS

Healthcare · Biotechnology

Loading chart data...

Current StateBalance holding

The verdict

Good business

Weak

Revenue growth-13.4% / yr

Operating margin-485.1%

ROIC-259.9%

Financially safe

Stretched

Debt / equity0.11×

Interest coverage0.0×

Current ratio1.00×

Curis, Inc.

CRISNASDAQ·USD·Closed

Curis, Inc.

CRISNASDAQ·USD·Closed

$5.02

+1.25%

$5.02

+$0.06 (1.25%)

52W Range

4thpctl

Volume

0.08×avg

Mkt Cap

9.78MUSD

P/E

-0.2TTM

Div Yield

–ann

52W Range

4thpctl

Volume

0.08×avg

Market Cap

9.78MUSD

P/E Ratio

-0.2TTM

Div Yield

-ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings